LSP (Life Sciences Partners)
Stockholm · Series A–Late Stage · 42 people tracked
Investment thesis
EQT Life Sciences invests in innovative life sciences companies addressing unmet clinical needs across therapeutics, medical devices, diagnostics, and healthtech. The firm combines capital deployment with strategic, clinical, operational, financial, and commercial support to help transform cutting-edge scientific innovation into impactful healthcare solutions that improve patient outcomes. The team leverages deep medical and scientific expertise to back the most promising inventors and entrepreneurs globally.
Source: firm website, verified Jul 17, 2026.
Team · 42 people
from the firm's websiteInvestments · 5 tracked
- Amolyt Pharma
- Neuravi
- NewAmsterdam Pharma
- Onera Health
- PanTera
Frequently asked questions
- What stage does LSP (Life Sciences Partners) invest at?
- LSP (Life Sciences Partners) invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What is LSP (Life Sciences Partners)'s typical check size?
- LSP (Life Sciences Partners) typically writes checks of $11M – $66M.
- What sectors does LSP (Life Sciences Partners) focus on?
- LSP (Life Sciences Partners) focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is LSP (Life Sciences Partners) located?
- LSP (Life Sciences Partners) is headquartered in Stockholm, SE.
- Does LSP (Life Sciences Partners) lead rounds?
- Yes, LSP (Life Sciences Partners) leads investment rounds.
Similar investors
A deep technology venture capital firm investing in companies solving major global challenges across climate change, human health, defense, security, space, and physically intensive industries.
Oak is a multi-stage venture capital firm investing in high-growth opportunities across information technology, internet, consumer, financial services technology, healthcare information and services, and clean energy sectors. The firm has deployed approximately $9 billion across over 525 companies globally since its founding.
Octopus Ventures is a major venture capital investor in Europe focused on backing entrepreneurs addressing global challenges across sustainability, human empowerment, and healthcare innovation.
Osage University Partners invests in breakthrough startups emerging from leading research labs and innovation ecosystems, with a focus on tech and life science companies. The firm manages $800 million and has 150+ portfolio companies across all investment stages from pre-seed to crossover.
B Capital is an investment firm led by Eduardo Saverin, Raj Ganguly, and Howard Morgan that supports early to late-stage innovators across technology, healthcare, energy, and resilience sectors. The firm leverages an in-house platform team and strategic partnership with Boston Consulting Group to provide founders with strategic support, market knowledge, and operational tools.